AptbIo.com
About AptbIo.com
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases. The company’s lead program, inhaled cyclosporine, is in Phase III for the prevention of chronic lung transplant rejection. For more information on the Phase III trial, visit the study website at www.cycliststudy.
